TipRanks
Alcon Inc (CH:ALC)
:ALC
Switzerland Market
Want to see CH:ALC full AI Analyst Report?

Alcon (ALC) Stock Forecast & Price Target

21 Followers
See the Price Targets and Ratings of:

ALC Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
7 Buy
4 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Alcon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALC Stock 12 Month Forecast

Average Price Target

CHF68.80
▲(17.17% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is CHF68.80 with a high forecast of CHF85.00 and a low forecast of CHF48.00. The average price target represents a 17.17% change from the last price of CHF58.72.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"47":"CHF47","86":"CHF86","56.75":"CHF56.8","66.5":"CHF66.5","76.25":"CHF76.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF85.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68.80198123981819,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF68.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF48.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[47,56.75,66.5,76.25,86],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.86,55.332307692307694,57.80461538461538,60.276923076923076,62.74923076923077,65.22153846153846,67.69384615384615,70.16615384615385,72.63846153846154,75.11076923076922,77.58307692307693,80.05538461538461,82.5276923076923,{"y":85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.86,54.08630624921678,55.312612498433566,56.53891874765035,57.76522499686713,58.991531246083916,60.2178374953007,61.44414374451749,62.670449993734266,63.89675624295106,65.12306249216783,66.34936874138462,67.5756749906014,{"y":68.80198123981819,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.86,52.48615384615385,52.112307692307695,51.738461538461536,51.364615384615384,50.99076923076923,50.61692307692308,50.24307692307692,49.86923076923077,49.495384615384616,49.121538461538464,48.747692307692304,48.37384615384615,{"y":48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":59.132,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.431,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.974,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.024,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.789,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.938,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.72,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.78,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.38,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.3,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.86,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF85.00Average Price TargetCHF68.80Lowest Price TargetCHF48.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham
CHF80.8
Buy
37.60%
Upside
Reiterated
10/21/26
Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Odyssey Therapeutics, Inc. (NASDAQ: ODTX)
Mizuho Securities Analyst forecast on CH:ALC
Mizuho Securities
Mizuho Securities
CHF70.08→CHF65.96
Buy
12.33%
Upside
Reiterated
10/13/26
Alcon price target lowered to $80 from $85 at MizuhoAlcon price target lowered to $80 from $85 at Mizuho
Barclays
CHF57.72
Hold
-1.71%
Downside
Initiated
10/06/26
Alcon initiated with an Equal Weight at BarclaysAlcon initiated with an Equal Weight at Barclays
Stifel Nicolaus Analyst forecast on CH:ALC
Stifel Nicolaus
Stifel Nicolaus
CHF53.04→CHF57.72
Hold
-1.71%
Downside
Reiterated
10/06/26
Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), BioNTech SE (NASDAQ: BNTX) and Anixa Biosciences (NASDAQ: ANIX)
Bank of America Securities Analyst forecast on CH:ALC
Bank of America Securities
Bank of America Securities
CHF48
Sell
-18.26%
Downside
Reiterated
10/05/26
Alcon: Underperform Rating Reiterated as Analyst Flags Mounting Headwinds; $48 Price Target Maintained
Jefferies Analyst forecast on CH:ALC
Jefferies
Jefferies
CHF70.08
Buy
19.35%
Upside
Reiterated
09/22/26
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NYSE: NVO) and Alcon (NYSE: ALC)
Wells Fargo Analyst forecast on CH:ALC
Wells Fargo
Wells Fargo
CHF70.91
Buy
20.75%
Upside
Reiterated
09/18/26
Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)
Berenberg Bank Analyst forecast on CH:ALC
Berenberg Bank
Berenberg Bank
CHF85
Buy
44.75%
Upside
Reiterated
09/10/26
Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and AbbVie (NYSE: ABBV)
Deutsche Bank  Analyst forecast on CH:ALC
Deutsche Bank
Deutsche Bank
CHF70→CHF73
Buy
24.32%
Upside
Reiterated
08/17/26
Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank
UBS
CHF86→CHF83
Buy
41.35%
Upside
Reiterated
08/14/26
Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)
William Blair Analyst forecast on CH:ALC
William Blair
William Blair
―
Hold
―
Assigned
08/12/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)
J.P. Morgan Analyst forecast on CH:ALC
J.P. Morgan
J.P. Morgan
CHF64.64
Hold
10.08%
Upside
Reiterated
08/12/26
J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)
Argus Research Analyst forecast on CH:ALC
Argus Research
Argus Research
CHF70.08
Buy
19.35%
Upside
Reiterated
07/01/26
Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus
KeyBanc
CHF72.56
Buy
23.56%
Upside
Reiterated
06/12/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)
Citi
CHF92.34→CHF84.92
Buy
44.62%
Upside
Reiterated
06/11/26
Alcon (ALC) Gets a Buy from Citi
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham
CHF80.8
Buy
37.60%
Upside
Reiterated
10/21/26
Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Odyssey Therapeutics, Inc. (NASDAQ: ODTX)
Mizuho Securities Analyst forecast on CH:ALC
Mizuho Securities
Mizuho Securities
CHF70.08→CHF65.96
Buy
12.33%
Upside
Reiterated
10/13/26
Alcon price target lowered to $80 from $85 at MizuhoAlcon price target lowered to $80 from $85 at Mizuho
Barclays
CHF57.72
Hold
-1.71%
Downside
Initiated
10/06/26
Alcon initiated with an Equal Weight at BarclaysAlcon initiated with an Equal Weight at Barclays
Stifel Nicolaus Analyst forecast on CH:ALC
Stifel Nicolaus
Stifel Nicolaus
CHF53.04→CHF57.72
Hold
-1.71%
Downside
Reiterated
10/06/26
Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), BioNTech SE (NASDAQ: BNTX) and Anixa Biosciences (NASDAQ: ANIX)
Bank of America Securities Analyst forecast on CH:ALC
Bank of America Securities
Bank of America Securities
CHF48
Sell
-18.26%
Downside
Reiterated
10/05/26
Alcon: Underperform Rating Reiterated as Analyst Flags Mounting Headwinds; $48 Price Target Maintained
Jefferies Analyst forecast on CH:ALC
Jefferies
Jefferies
CHF70.08
Buy
19.35%
Upside
Reiterated
09/22/26
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NYSE: NVO) and Alcon (NYSE: ALC)
Wells Fargo Analyst forecast on CH:ALC
Wells Fargo
Wells Fargo
CHF70.91
Buy
20.75%
Upside
Reiterated
09/18/26
Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)
Berenberg Bank Analyst forecast on CH:ALC
Berenberg Bank
Berenberg Bank
CHF85
Buy
44.75%
Upside
Reiterated
09/10/26
Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and AbbVie (NYSE: ABBV)
Deutsche Bank  Analyst forecast on CH:ALC
Deutsche Bank
Deutsche Bank
CHF70→CHF73
Buy
24.32%
Upside
Reiterated
08/17/26
Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank
UBS
CHF86→CHF83
Buy
41.35%
Upside
Reiterated
08/14/26
Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)
William Blair Analyst forecast on CH:ALC
William Blair
William Blair
―
Hold
―
Assigned
08/12/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)
J.P. Morgan Analyst forecast on CH:ALC
J.P. Morgan
J.P. Morgan
CHF64.64
Hold
10.08%
Upside
Reiterated
08/12/26
J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)
Argus Research Analyst forecast on CH:ALC
Argus Research
Argus Research
CHF70.08
Buy
19.35%
Upside
Reiterated
07/01/26
Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus
KeyBanc
CHF72.56
Buy
23.56%
Upside
Reiterated
06/12/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)
Citi
CHF92.34→CHF84.92
Buy
44.62%
Upside
Reiterated
06/11/26
Alcon (ALC) Gets a Buy from Citi
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
ONCBeOne Medicines
IRLAIRulya Therapeutics
IDYAIDEAYA Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alcon

3 Months
Larry BiegelsenWells Fargo
Success Rate
14/20 ratings generated profit
70%
Average Return
+2.15%
Copying Larry Biegelsen's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +2.15% per trade.
1 Year
Larry BiegelsenWells Fargo
Success Rate
13/20 ratings generated profit
65%
Average Return
+4.22%
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 65.00% of your transactions generating a profit, with an average return of +4.22% per trade.
2 Years
Larry BiegelsenWells Fargo
Success Rate
11/20 ratings generated profit
55%
Average Return
+2.52%
Copying Larry Biegelsen's trades and holding each position for 2 Years would result in 55.00% of your transactions generating a profit, with an average return of +2.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALC Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
3
4
2
2
1
Buy
9
8
8
9
9
Hold
5
4
2
3
5
Sell
2
2
1
1
1
Strong Sell
0
0
0
0
0
total
19
18
13
15
16
In the current month, ALC has received 10 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. ALC average Analyst price target in the past 3 months is 68.80.
Each month's total comprises the sum of three months' worth of ratings.

ALC Financial Forecast

ALC Earnings Forecast

Next quarter’s earnings estimate for ALC is CHF0.72 with a range of CHF0.66 to CHF0.77. The previous quarter’s EPS was CHF0.68. ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALC is CHF0.72 with a range of CHF0.66 to CHF0.77. The previous quarter’s EPS was CHF0.68. ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Sales Forecast

Next quarter’s sales forecast for ALC is CHF2.24B with a range of CHF2.20B to CHF2.29B. The previous quarter’s sales results were CHF2.23B. ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.
Next quarter’s sales forecast for ALC is CHF2.24B with a range of CHF2.20B to CHF2.29B. The previous quarter’s sales results were CHF2.23B. ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Stock Forecast FAQ

What is CH:ALC’s average 12-month price target, according to analysts?
Based on analyst ratings, Alcon Inc’s 12-month average price target is 68.80.
    What is CH:ALC’s upside potential, based on the analysts’ average price target?
    Alcon Inc has 17.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Alcon Inc a Buy, Sell or Hold?
          Alcon Inc has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 1 sell ratings.
            What is Alcon Inc’s share price target?
            The average share price target for Alcon Inc is 68.80. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF85.00 ,and the lowest forecast is CHF48.00. The average share price target represents 17.17% Increase from the current price of CHF58.72.
              What do analysts say about Alcon Inc?
              Alcon Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Alcon Inc?
                To buy shares of CH:ALC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.